Notably, as illustrated in Fig. 6a, A-f-M13-MB successfully captured over 92.21% of MUC1 positive cancer cells (MCF-7, A549), whereas the capture efficiencies for negative cells (HepG2, SK-Hep-1) were markedly lower, falling below 13.01%. Here, MUC1 is linked to cancer.